Cyto-KIK: A phase II trial of cytoreductive surgery in kidney cancer plus immunotherapy (nivolumab) and targeted kinase inhibition (cabozantinib). Background: The majority of non- prostate ...

TAMPA, Fla. — Patient-reported outcomes are important indicators of how cancer drugs impact patients’ lives. By assessing the benefits and risks of drugs from a patient’s perspective, scientists and ...

RNA originating from genitourinary tract tissues is resolvable at cell-type resolution in human urine. Study: Deconvolution of Human Urine across the Transcriptome and Metabolome. Image Credit: ...

Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies Palliative care (PC) plays a critical role in managing the ...

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its planned presence at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), including three accepted ...

PROEAS graph reporting the different PROEAS scores per category for randomized clinical trials individualized by GU tumor type. Abbreviations: PROEAS: Patient Reported Outcome Endpoint Analysis Score; ...